Brief: Daewoong Pharma Reports Q3 Standalone Revenue Krw 301.5 Bln
15/11/2022 12:39
Nov 15 (Reuters) - Daewoong Pharma 069620.KS :
* DAEWOONG PHARMA Q3 STANDALONE REVENUE KRW 301.5 BILLION
* DAEWOONG PHARMA - QTRLY CONSOLIDATED REVENUE STOOD AT KRW
331.9
BILLION
Source text for Eikon: ID:nPncjrxna
Further company coverage: 069620.KS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Daewoong Pharma
See all newsBrief: Daewoong Pharma Q2 Operating. Profit 77 Billion Won, Up 23% Y/Y
Brief: Daewoong Pharma Wins 92.6 Billion Won Order
Brief: Daewoong Pharma Q4 Operating Profit 45.5 Billion Won, Up 9% From Year Earlier
Brief: Daewoong Pharma Q2 Operating Profit 62.5 Billion Won, Up 26% From Year Earlier
Brief: Daewoong Pharma Q1 Operating Profit 42 Billion Won, Up 34.5% From Year Earlier